OTCMKTS:HPST

Hempstract Stock Forecast, Price & News

$0.45

-0.04 (-8.16 %)

(As of 03/1/2021 12:00 AM ET)

Add

Compare

Today's Range

$0.30

Now: $0.45▼

$0.47

50-Day Range

$0.38

MA: $0.56▼

$0.73

52-Week Range

$0.07

Now: $0.45▼

$2.17

Volume140,011 shs

Average Volume271,827 shs

Market Capitalization$44.86 million

P/E RatioN/A

Dividend YieldN/A

Beta-7.81

Hempstract, Inc. produces and sells cannabidiol (CBD) and cannabigerol solutions in the United States. It offers CBD isolate powder and distillate oil. The company was formerly known as Riverdale Oil and Gas Corporation and changed its name to Hempstract, Inc. in November 2020. Hempstract, Inc. is based in Warden, Washington.

Headlines

Hempstract, Inc.: Hempstract Inc. Completes First Round of CBD Extraction
January 5, 2021 | finanznachrichten.de

Hempstract Inc. Completes First Round of CBD Extraction
January 5, 2021 | finance.yahoo.com

Riverdale Oil & Gas Corporation Announces Name Change and Ticker Symbol Change to Hempstract Inc., (OTC PINK:HPST)
January 4, 2021 | finance.yahoo.com

Hempstract, Inc. Expands Product Offerings and Leadership
January 4, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Crude petroleum & natural gas

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:HPST

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.hempstractlabs.com

Phone800-748-5035

Employees2

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares99,691,000

Market Cap$44.86 million

Next Earnings DateN/A

OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

Medical Sector

1882nd out of 1,966 stocks

Crude Petroleum & Natural Gas Industry

237th out of 247 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Hempstract.

0.0 Community Rank

Outperform Votes
Hempstract has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Hempstract has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Hempstract and other stocks. Vote “Outperform” if you believe HPST will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HPST will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Hempstract does not currently pay a dividend.
Dividend Growth
Hempstract does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Hempstract insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 28.10% of the stock of Hempstract is held by insiders.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

$0.45

-0.04 (-8.16 %)

(As of 03/1/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive HPST News and Ratings via Email

Sign-up to receive the latest news and ratings for HPST and its competitors with MarketBeat's FREE daily newsletter.

Hempstract (OTCMKTS:HPST) Frequently Asked Questions

What stocks does MarketBeat like better than Hempstract?

Wall Street analysts have given Hempstract a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Hempstract wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Hempstract?

Hempstract saw a increase in short interest in February. As of February 12th, there was short interest totaling 34,800 shares, an increase of 3,063.6% from the January 28th total of 1,100 shares. Based on an average daily trading volume, of 425,400 shares, the days-to-cover ratio is presently 0.1 days.
View Hempstract's Short Interest.

Who are Hempstract's key executives?

Hempstract's management team includes the following people:

Mr. Ronald M. Herzfeld, CEO & Director
Mr. Michael B. Glazer, Sec.
Ms. Linda Ellis, VP

Who are some of Hempstract's key competitors?

Some companies that are related to Hempstract include PEDEVCO (PED), Goodrich Petroleum (GDP), Evolution Petroleum (EPM), Amplify Energy (AMPY), TransGlobe Energy (TGA), Obsidian Energy (OBELF), SilverBow Resources (SBOW), PrimeEnergy Resources (PNRG), Epsilon Energy (EPSN), Painted Pony Energy (PDPYF), Trans Energy (TENG), PHX Minerals (PHX), PermRock Royalty Trust (PRT), VOC Energy Trust (VOC) and MV Oil Trust (MVO).
View all of HPST's competitors.

What is Hempstract's stock symbol?

Hempstract trades on the OTCMKTS under the ticker symbol "HPST."

How do I buy shares of Hempstract?

Shares of HPST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Hempstract's stock price today?

One share of HPST stock can currently be purchased for approximately $0.45.

How much money does Hempstract make?

Hempstract has a market capitalization of $44.86 million.

How many employees does Hempstract have?

Hempstract employs 2 workers across the globe.

What is Hempstract's official website?

The official website for Hempstract is www.hempstractlabs.com.

Where are Hempstract's headquarters?

Hempstract is headquartered at 16152 Beach Boulevard, Huntington Beach CA, .

How can I contact Hempstract?

Hempstract's mailing address is 16152 Beach Boulevard, Huntington Beach CA, . The company can be reached via phone at 800-748-5035.

This page was last updated on 3/2/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here